Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:
Clinical data transparency update – TransCelerate BioPharma
TransCelerate, a nonprofit that collaborates with the global biopharmaceutical community, announced that it has successfully completed all of its Clinical Data Transparency Initiative objectives. The initiative entailed authoring assets that provide redaction, anonymization, and lay summary distribution guidance.
Read the full announcement here
Clinical trial transparency – who’s watching? – Open Pharma
The Center for Biomedical Research Transparency (CBMRT) brought various academic publishing stakeholders together to discuss their views on research transparency. The stakeholders discussed policy recommendations, special tools to increase transparency, and changes in the academic publishing industry.
Steph MacDonald has the full story via Open Pharma
The unreported results that are still undermining evidence-based medicine – Cancerworld
When brought to light on a large scale, unreported clinical trials have prompted various responses from legislative bodies. Science writer Sophie Fessl asks what impact these changes have had on reporting practices today.
Read Sophie Fessl’s full article on Cancerworld
Event alert: Publication and Clinical Trial Transparency Conference – CBI
The eighth annual CBI conference will take place on June 11-12 in Amsterdam. Topics discussed this year include trends in data sharing, regulatory guidance, and an anonymization workshop.
Learn more about this event here
